Clinical trial Recruiting at 1 site Interventional Ages 18 to 60

Lycium barbarum polysaccharide for dry eye symptoms in adults

Official title: Efficacy of Lycium Barbarum Polysaccharide in Dry Eye Disease Management : A Pilot Study

Run by The Hong Kong Polytechnic University · NCT07842536 · Data updated 2026-11-12

Adults with dry eye disease will try taking Lycium barbarum polysaccharide tablets twice daily for 12 weeks to see if their symptoms and eye tests improve and to check safety.

More Dry Eye Syndromes trials

Quick facts

Study typeInterventional
Ages18 Years to 60 Years
SexAll
Enrollment30 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hong Kong, Hong Kong)
StatusRecruiting
StartedSeptember 14, 2026
Main results expectedJanuary 1, 2027
Study endsAugust 1, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT07842536 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–60 with a clinical diagnosis of dry eye disease and a dry eye symptom burden (OSDI-12 score ≥ 13) plus at least one clinical sign.

Probably not a fit

Some participants may not experience symptom relief or objective improvement in tear film or ocular surface metrics.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study tests whether oral Lycium barbarum polysaccharide (LBP) can improve symptoms and clinical signs of dry eye disease in adults. Participants will take LBP twice daily for 12 weeks and attend visits at baseline, 4 weeks, and 12 weeks for questionnaires and eye examinations measuring tear film, tear production, and ocular surface health. The study will provide preliminary data on safety and potential benefits to guide future larger trials. It employs standardized optometric assessments in a clinical research setting to characterize changes over time. Outcomes will inform whether further investigation in a controlled trial is warranted.

Why it matters

Potential benefit: If successful, participants may experience reduced dry eye symptoms and improved ocular surface health during the study period.

How similar studies have gone: Clinical data on oral LBP for dry eye are limited; this pilot study will provide initial insights for future research.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 18 to 60 years at enrollment.
* Clinical diagnosis of dry eye disease, defined as OSDI-12 score \>=13 and at least one clinical sign of dry eye disease.
* Habitual visual acuity 6/9 or better in both eyes.
* Able to understand the study procedures and provide written informed consent.

Exclusion Criteria:

* Ocular infection within 3 months before enrollment or ocular disease other than dry eye disease.
* History of ocular surgery, including refractive surgery.
* Use of dry eye-related products, such as artificial tears, within 1 month before enrollment.
* Contact lens wear within 1 month before enrollment.
* Long-term use of medications known to affect dry eye symptoms.
* Severe or unstable systemic disease.
* Infectious disease, such as viral influenza.
* Known allergy or hypersensitivity to Lycium barbarum polysaccharide.
* Pregnant or breastfeeding.
* Any condition that, in the investigator's judgment, makes the participant unsuitable for the study.

Where it's running

  • The Hong Kong Polytechnic University, School of Optometry, Optometry Clinic
    Hong Kong, Hong Kong, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.